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Summary
Objective: To determine the speciﬁcity and efﬁciency of the tamoxifen (TM)-induced Cre-recombination in articular chondrocytes of adult
Col2a1-CreERT2 transgenic mice.
Methods: Col2a1-CreERT2 transgenic mice were bred with Rosa26 reporter mice. Two-week-old Col2a1-CreERT2;R26R mice were adminis-
tered TM for 5 days and were sacriﬁced 1 and 6 months after TM induction. X-Gal staining was performed.
Results: Efﬁcient Cre-recombination is achieved in adult articular chondrocytes 1 and 6 months after TM induction.
Conclusion: Our ﬁndings demonstrate that the Col2a1-CreERT2 transgenic mouse model is a valuable tool to target genes speciﬁcally
expressed in articular chondrocytes in a temporally controlled manner in adult mice.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction recombination was observed in growth plate chondrocytesOsteoarthritis (OA) is a degenerative joint disease that is
common in ageing and occurs in both humans and animals.
Alternations of gene expression in articular chondrocytes
likely play an important role in the development of OA1e3.
Articular chondrocytes are the only cell type in articular
cartilage and they produce and maintain the extracellular
matrix, which is responsible for providing the appropriate
function to articular tissue4. Articular cartilage has minimal
reparative potential and degradation of articular cartilage
can have severe consequences. For this reason, envision-
ing strategies to maintain articular cartilage is an important
objective in the arthritis ﬁeld. Unfortunately, very little is
known regarding the mechanisms involved in establishing
and maintaining the articular chondrocyte phenotype.
In order to target chondrocyte-speciﬁc genes in a tissue-
speciﬁc and inducible manner, we have recently generated
a transgenic mouse model, Col2a1-CreERT2, in which the
expression of the Cre recombinase is driven by the chon-
drocyte-speciﬁc col2a1 promoter in a TM-inducible fashion.
We have previously reported that chondrocyte-speciﬁc Cre-1This work was supported by grants R01 AR051189, R01
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129of these mice postnatally5. In the present study, we show
that Cre-recombination is maintained in articular chondro-
cytes of adult transgenic mice.Methods, results and discussion
Col2a1-CreERT2 transgenic mice were crossed with
Rosa26 reporter mice in which the expression of Escherichia
coli b-galactosidase can be induced by Cre-mediated recom-
bination6,7. Offspring were genotyped by polymerase chain
reaction (PCR) using Cre-speciﬁc primers and primers for
detecting R26R alleles. The sequences of PCR primers for
genotyping Col2a1-CreERT2mice are: 50-CCTGGAAAATGC
TTCTGTCCGTTTGCC-30 (forward primer) and 50-GAGTTG
ATAGCTGGCTGGTGGCAGAG-30 (reverse primer) and the
size of the PCR product is 600 bp. The sequences of PCR
primers for genotyping Rosa26 reporter mice are: R1295,
50-GCGAAGAGTTTGTCCTCAACC-30; R523, 50-GGAGCG
GGAGAAATGGATATG-30 and R26F2, 50-AAAGTCGCTCT
GAGTTGTTAT-30. The 600-bp PCR product was detected in
wild-type mice and the 325-bp PCR product was detected in
homozygous Rosa26 mice. In heterozygous Rosa26 reporter
mice, both 600 and 325-bp PCR products were detected.
To determine whether the Col2a1-CreERT2 transgenic
mice can beused to target genes expressed in articular chon-
drocytes in adult mice, they were bred with Rosa26 reporter
mice to follow the time course of reporter expression.
TM induction was performed in 2-week-oldCol2a1-CreERT2;
R26R transgenics (1 mg TM/mouse/day for 5 days) andmice
were sacriﬁced 1 and 6 months after the last injection. The
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T2 transgenic micelong boneswere harvested and ﬁxed in 0.2%glutaraldehyde,
decalciﬁed and processed for frozen sectioning followed by
X-Gal staining. Nuclear Fast Red staining was performed
as a counter stain. The recombination efﬁciency was deter-
mined by counting theX-Gal-positive cells divided by the total
number of cells on the articular surface (n¼ 4). The results
showed that TM induced efﬁcient Cre-recombination in artic-
ular chondrocytes 1 and 6 months after TM induction
[Fig. 1(a,b)]. Eighty-ﬁve percent and 82%Cre-recombination
efﬁciency were achieved in articular cartilage area of these
mice [Fig. 1(a,b)] (n¼ 4). It should be noted that some cells
in the deep zone of the articular cartilage were negative forFig. 1. Histological analyses of the Col2a1-Creþ/ERT2;R26Rþ/
mice. Two-week-old Col2a1-Creþ/ERT2;R26Rþ/ double transgenic
mice and Cre-negative control littermates were injected with TM
(1 mg TM/mouse/day for 5 days). Mice were sacriﬁced 1 (a) and 6
months (b) after injectionswere completed and samples of long bones
were ﬁxed, decalciﬁed and processed for frozen section preparation
followed by X-Gal staining. Sections were then counterstained with
Nuclear Fast Red. Articular chondrocytes of double transgenic mice
that received TMshowed X-Gal-positive staining (a,b). Recombination
efﬁciencywasevaluatedbycounting theX-Gal-positivecells dividedby
total cell numbers in articular cartilage area from threenon-consecutive
histological sections of four transgenic mice (n¼ 4). High Cre-
recombination efﬁciency was achieved in articular chondrocytes
of the transgenic mice 1 and 6 months after TM induction.X-Gal staining; this may be due to the poor penetration of
tamoxifen (TM) into these areas.
Overall, these results suggest that Col2a1-CreERT2
transgenic mice provide a strategy for causing tissue-
speciﬁc gene deletion in a temporal manner. Since the per-
centage of X-Gal-positive articular chondrocytes is similar
at 1 and 6 months after TM induction, there is likely minimal
turnover or cell renewal in articular cartilage, consistent with
the limited reparative potential of this tissue.
Using the 3-kb Col2a1 promoter, Ovchinnikov et al.8
generated Col2a1-Cre transgenic mice which show efﬁcient
Cre-recombination in chondrocytes during mouse develop-
ment. A similar approach was also reported by Nakamura
et al.9 who generated Col2a1-CreERT transgenic mice using
the sameCol2a1 promoter construct as we used in our trans-
genic mice. Although efﬁcient Cre-recombination was dem-
onstrated in the skeleton of embryonic and postnatal
stages, it becomes undetectable in 12-week-old Col2a1-
CreERT transgenic mice9. Several factors such as differ-
ences in transgene constructs, integration sites and copy
numbers may contribute to these phenotypic distinctions.
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